Galán-Gómez, Víctor
González-Martínez, Berta
Alonso-Saladrigues, Anna
Rives, Susana
Herrero, Blanca
Kwon, Mi
Sánchez-Pina, Jose
Minguillón, Jordi
Martínez-Romera, Isabel
Mirones Aguilar, Isabel
Mestre-Durán, Carmen
Casado, Gema
Sánchez-Martín, María
Echecopar, Carlos
González-Pérez, Carlos
León-Triana, Odelaisy
Aguirre-Portolés, Cristina
Molinos-Quintana, Águeda
Barba, Pere
Balsalobre, Pascual
Pérez-Martínez, Antonio
Funding for this research was provided by:
Juan Rodés Contracts (AES 2024) of the Carlos III Health Institute through the European Funds of the Recovery, Transformation and Resilience Plan (JR24/00003)
Río Hortega Contracts (AES 2022) of the Carlos III Health Institute through the European Funds of the Recovery, Transformation and Resilience Plan (CM22/00078)
CRIS Cancer Foundation
Río Hortega Contracts (AES 2024) of the Carlos III Health Institute through the European Funds of the Recovery, Transformation and Resilience Plan (CM24/00111)
Juegaterapia Fundation
National Health Service of Spain, Carlos III Health Institute (ISCIII), FONDOS FEDER grant (PI22/01226)
Article History
Received: 18 December 2024
Accepted: 10 March 2025
First Online: 2 April 2025
Declarations
:
: The Institutional Review Board of La Paz University Hospital approved the study, and it was ratified by all participating centers (PI5630). The study was conducted in accordance with the Declaration of Helsinki (latest version, Fortaleza 2013), as well as with Spanish and EU laws and regulations applicable to observational studies. Written informed consent was obtained from the patients’ parents before data collection.
: The authors declare no competing interests.